Peer Review reports
From: C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
| Original Submission | ||
|---|---|---|
| 8 Jun 2017 | Submitted | Original manuscript |
| 30 Jun 2017 | Reviewed | Reviewer Report - Anindita Chakrabarty |
| 4 Jul 2017 | Reviewed | Reviewer Report - Prathibha Ranganathan |
| 14 Jul 2017 | Reviewed | Reviewer Report - Joan Garrett |
| 15 Oct 2017 | Author responded | Author comments - Wei Li |
| Resubmission - Version 2 | ||
| 15 Oct 2017 | Submitted | Manuscript version 2 |
| 15 Dec 2017 | Reviewed | Reviewer Report - Anindita Chakrabarty |
| 29 Dec 2017 | Reviewed | Reviewer Report - Prathibha Ranganathan |
| 3 Jan 2018 | Reviewed | Reviewer Report - Joan Garrett |
| 26 Feb 2018 | Author responded | Author comments - Wei Li |
| Resubmission - Version 3 | ||
| 26 Feb 2018 | Submitted | Manuscript version 3 |
| 10 Apr 2018 | Reviewed | Reviewer Report - Prathibha Ranganathan |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 17 Apr 2018 | Editorially accepted | |
| 2 May 2018 | Article published | 10.1186/s12885-018-4387-5 |
You can find further information about peer review here.